StockData
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31

Fortrea Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)

Close on Oct 19, 2026

Market cap
$2.13B
P/E (TTM)
–
Dividend yield
–

Fortrea Holdings Inc. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Clinical Services Segment$678.20M$636.50M$660.50M$701.30M$710.30M$651.30M$697.00M$674.90M$662.40M$662.10M$712.70M$711.70M100.0%-4.5%
Enabling Services––––––––––$65.70M$64.70M––
Operating incomeQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23YoY
Clinical Services Segment$14.80M-$3.40M-$13.60M-$8.60M-$330.30M-$520.10M-$55.60M-$18.00M-$50.90M-$37.40M-$160.40M$59.90M-104.5%
Enabling Services––––––––––$5.40M$2.30M–

By product or service

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
North America$319.70M$296.80M$303.10M$332.70M$344.30M$309.50M$325.10M$319.70M$317.90M$305.90M$324.80M$349.50M47.1%-7.1%
Europe$219.70M$213.90M$219.50M$213.20M$218.70M$200.30M$204.90M$191.80M$195.90M$208.30M$226.80M$204.30M32.4%+0.5%
Other$138.80M$125.80M$137.90M$155.40M$147.30M$141.50M$167.00M$163.40M$148.60M$147.90M$158.10M$160.00M20.5%-5.8%

From the segment and revenue-disaggregation notes of Fortrea's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.